Advertisement
Screener

Quanterix Corporation (QTRX) Borrowing debt

Quanterix Corporation (QTRX) Borrowing debt

  • Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2021-09-30..
  • Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2021-09-30..
  • Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2021-09-30..

Borrowing debt

Overview →

Financial period ending 2021-09-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
Total debt · latest quarter (USD)(m)Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2021-09-30.

Calculation unavailable: missing inputs remain (m).

Net cash · latest quarter(m)Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2021-09-30.

Calculation unavailable: missing inputs remain (m).

Debt / assets · latest quarter(m)Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2021-09-30.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Borrowing debt due within one year1.99M USDLong-term Debt, Current Maturities
Borrowing debt due after one year(m)Long-term Debt, Excluding Current Maturities
Commercial paper(m)
Cash and current securities(m)Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Debt Securities, Available-for-sale, Current
Borrowing debt(m)Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities
Total assets510.84M USDAssets

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingTotal debtNet cash / debtBorrowing debt due within one year (USD)Borrowing debt due after one year (USD)Commercial paper (USD)Cash and current securities (USD)Total assets (USD)Debt / assets
2021-09-30(m)(m)$1.99M(m)(m)(m)$510.84M(m)
2021-06-30(m)(m)$7.72M(m)(m)(m)$528.04M(m)
2021-03-31(m)(m)$7.69M(m)(m)(m)$532.67M(m)
2020-12-31(m)(m)$7.67M(m)(m)(m)$271.05M(m)
2020-09-30(m)(m)$5.74M$1.91M(m)(m)$264.11M(m)
2020-06-30(m)(m)(m)$7.63M(m)(m)$162.94M(m)
2020-03-31(m)(m)(m)$7.61M(m)(m)$170.31M(m)
2019-12-31(m)(m)$75.00K$7.59M(m)(m)$169.95M(m)
2019-09-30(m)(m)$75.00K$7.57M(m)(m)$175.54M(m)
2019-06-30(m)(m)$75.00K$7.54M(m)(m)$109.41M(m)
2019-03-31(m)(m)$75.00K$7.57M(m)(m)$65.18M(m)
2018-12-31(m)(m)(m)$7.62M(m)(m)$67.61M(m)
2018-09-30(m)(m)(m)$7.59M(m)(m)$71.19M(m)
2018-06-30(m)(m)$7.61M(m)(m)(m)$77.77M(m)
2018-03-31(m)(m)$8.46M(m)(m)(m)$83.68M(m)
2017-12-31(m)(m)$5.04M$4.35M(m)(m)$91.78M(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
EyePoint, Inc. (EYPT)United States$0.314B-3.96
908 Devices Inc. (MASS)United States$0.476B-9.53
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15